The use of CLL-IPI, a new prognostic index for CLL
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
How clinicans should talk to CLL patients about their hopes and expectations
How does a patient’s personal situation affect CLL treatment choice?
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma